(−)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions

(−)-Epigallocatechin gallate (EGCG) exerts multiple beneficial effects on cardiovascular performance. In this study, we aimed to examine the effects of EGCG on diabetic cardiomyopathy during myocardial ischemia/reperfusion (I/R) injury. EGCG (100 mg/kg/day) was administered at week 6 for 2 weeks to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yang, Xia, Zhong-Yuan, Zhao, Bo, Leng, Yan, Dou, Juan, Meng, Qing-Tao, Lei, Shao-Qing, Chen, Zhi-Ze, Zhu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504977/
https://www.ncbi.nlm.nih.gov/pubmed/28714516
http://dx.doi.org/10.3892/ijmm.2017.3014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504977/
https://www.ncbi.nlm.nih.gov/pubmed/28714516
http://dx.doi.org/10.3892/ijmm.2017.3014

Ejemplares similares